Circulating cell-free microRNAs as clinical cancer biomarkers
V Armand-Labit, A Pradines - Biomolecular concepts, 2017 - degruyter.com
MicroRNAs (miRNAs) are non-coding small RNAs that are master regulators of genic
expression and consequently of many cellular processes. But their expression is often …
expression and consequently of many cellular processes. But their expression is often …
[HTML][HTML] Early diagnosis of lung cancer: which is the optimal choice?
J Ning, T Ge, M Jiang, K Jia, L Wang, W Li… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
The prognosis of lung cancer patients with different clinical stages is significantly different.
The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be …
The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be …
Hydrogel-coated microneedle arrays for minimally invasive sampling and sensing of specific circulating nucleic acids from skin interstitial fluid
D Al Sulaiman, JYH Chang, NR Bennett, H Topouzi… - ACS …, 2019 - ACS Publications
Minimally invasive technologies that can sample and detect cell-free nucleic acid
biomarkers from liquid biopsies have recently emerged as clinically useful for early …
biomarkers from liquid biopsies have recently emerged as clinically useful for early …
[HTML][HTML] Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis
E Cosar, R Mamillapalli, GS Ersoy, SY Cho, B Seifer… - Fertility and sterility, 2016 - Elsevier
Objective To investigate serum microRNAs (miRNAs) in women with endometriosis. Design
Case-control study. Setting University hospital. Patient (s) Women with (n= 24) and without …
Case-control study. Setting University hospital. Patient (s) Women with (n= 24) and without …
[HTML][HTML] Exosomal microRNA in plasma as a non‑invasive biomarker for the recurrence of non‑small cell lung cancer
H Dejima, H Iinuma, R Kanaoka… - Oncology …, 2017 - spandidos-publications.com
Predictive biomarkers for the recurrence of non‑small cell lung cancer (NSCLC) in patients
who have received curative resection are important for cancer treatment. The functional …
who have received curative resection are important for cancer treatment. The functional …
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
NS Lai, DG Wu, XG Fang, YC Lin, SS Chen… - British journal of …, 2015 - nature.com
Background: MicroRNA-210 (miR-210) is an oncogenic miRNA previously associated with
prognosis in human gliomas, an incurable tumour type of the central nervous system. Here …
prognosis in human gliomas, an incurable tumour type of the central nervous system. Here …
Serum miRNA signatures are indicative of skeletal fractures in postmenopausal women with and without type 2 diabetes and influence osteogenic and adipogenic …
U Heilmeier, M Hackl, S Skalicky… - Journal of Bone and …, 2016 - academic.oup.com
Standard DXA measurements, including Fracture Risk Assessment Tool (FRAX) scores,
have shown limitations in assessing fracture risk in Type 2 Diabetes (T2D), underscoring the …
have shown limitations in assessing fracture risk in Type 2 Diabetes (T2D), underscoring the …
Quantitative and Multiplex Detection of Extracellular Vesicle‐Derived MicroRNA via Rolling Circle Amplification within Encoded Hydrogel Microparticles
D Al Sulaiman, N Juthani… - Advanced healthcare …, 2022 - Wiley Online Library
Extracellular vesicle‐derived microRNA (EV‐miRNA) represent a promising cancer
biomarker for disease diagnosis and monitoring. However, existing techniques to detect EV …
biomarker for disease diagnosis and monitoring. However, existing techniques to detect EV …
Diagnosing lung cancers through examination of micro-RNA biomarkers in blood, plasma, serum and sputum: a review and summary of current literature
J Gyoba, S Shan, W Roa, ELR Bédard - International journal of molecular …, 2016 - mdpi.com
Lung cancer is the leading cause of cancer related morbidity and mortality worldwide.
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …
Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients …
Circulating microRNA biomarkers for lung cancer detection in Western populations
H Yu, Z Guan, K Cuk, H Brenner, Y Zhang - Cancer medicine, 2018 - Wiley Online Library
Lung cancer (LC) is a leading cause of cancer‐related death in the Western world. Patients
with LC usually have poor prognosis due to the difficulties in detecting tumors at early …
with LC usually have poor prognosis due to the difficulties in detecting tumors at early …